未登录

J

Jody L. Green

inflexxion

H指数:25

被引数:4,606

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications

丁丙诺啡产品用于疼痛治疗：与全μ-阿片受体激动剂药物相比的滥用相对风险及相关临床结局

Pain and Therapy

IF3.3

2026-04-150

OAAI

Postmarketing Research for Opioid Abuse-Deterrent Formulations: A Narrative Review

阿片类药物滥用阻制剂的上市后研究：一篇叙述性综述

Journal of Pain Research

IF2.5

2025-08-090

OA

Sources of nonmedically used prescription psychotherapeutic drugs using real-world data from adolescents and adults assessed for substance use treatment--2014-2022

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2024-02-013

PRE

Pediatric Fatalities Associated With Over-the-Counter Cough and Cold Medications

与非处方咳嗽和感冒药相关的儿科死亡

IF6.4

2021-11-0114

OA

Non-medical Use of Prescription Stimulants Among College Students: Non-oral Routes of Administration, Risk Factors, Motivations, and Pathways

FRONTIERS IN PSYCHIATRY

IF3.2

2021-08-1610

OAAI

Characterizing Pathways of Non-oral Prescription Stimulant Non-medical Use Among Adults Recruited From Reddit

FRONTIERS IN PSYCHIATRY

IF3.2

2021-01-259

OAAI

Real-World Data on Nonmedical Use of Tramadol from Patients Evaluated for Substance Abuse Treatment in the NAVIPPRO Addiction Severity Index-Multimedia Version (ASI-MV(R)) Network

IF3.8

2020-11-119

OAAI

PATTERNS OF ABUSE OF PRESCRIPTION STIMULANT PRODUCTS FROM THE NATIONAL ADDICTIONS VIGILANCE INTERVENTION AND PREVENTION PROGRAM (NAVIPPRO®): 2010-2018

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

IF9.5

2020-10-010

PREAI

CHARACTERISTICS, NONORAL USE, AND PATHWAYS TO PRESCRIPTION STIMULANT (RXSTIM) NONMEDICAL USE IN COLLEGE STUDENTS

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

IF9.5

2020-10-010

PREAI

Impact of product safety changes on accidental exposures to liquid laundry packets in children

CLINICAL TOXICOLOGY

IF3.3

2020-09-225

OAAI

Trends in adverse events and related health-care facility utilization from cough and cold medication exposures in children

CLINICAL TOXICOLOGY

IF3.3

2020-09-115

OAAI

The impact of the prescription opioid epidemic on young children: Trends and mortality

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2020-06-0112

PREAI

Medication Errors From Over-the-Counter Cough and Cold Medications in Children

儿童非处方咳嗽和感冒药的用药错误

ACADEMIC PEDIATRICS

IF2.8

2020-04-0112

PREAI

How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users

JMIR PUBLIC HEALTH AND SURVEILLANCE

IF3.9

2020-03-254

OAAI

Flow Restrictors and Reduction of Accidental Ingestions of Over-the-Counter Medications

AMERICAN JOURNAL OF PREVENTIVE MEDICINE

IF4.5

2019-06-017

OAAI

Adverse events associated with diphenhydramine in children, 2008-2015

儿童苯海拉明相关不良事件，2008-2015

CLINICAL TOXICOLOGY

IF3.3

2019-05-0716

OAAI

UK survey of non-medical use of prescription drugs (NMURx) as a valuable source of general population illicit drug use data

英国非医疗使用处方药调查 (NMURx) 是普通人群非法药物使用数据的宝贵来源

POSTGRADUATE MEDICAL JOURNAL

IF2.7

2019-01-1110

OAAI

Evaluation of the quality and value of data sources for postmarket surveillance of the safety of cough and cold medications in children

BMC MEDICAL RESEARCH METHODOLOGY

IF3.4

2018-12-226

OAAI

Consistency Between Opioid-Related Mortality Trends Derived From Poison Center and National Vital Statistics System, United States, 2006-2016

AMERICAN JOURNAL OF PUBLIC HEALTH

IF9.6

2018-12-0124

OAAI

Frequency of Poison Center Exposures for Pediatric Accidental Unsupervised Ingestions of Acetaminophen after the Introduction of Flow Restrictors

JOURNAL OF PEDIATRICS

IF3.5

2018-07-0116

OAAI